Hydrogen Therapy Helps Lupus Patient Reduce Heart Problems and Fatigue
- Authors
- Yun-Ting Lin, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Hsiao-Chen Liu, Kuang-Yih Wang, Feng-Cheng Liu
- Journal
- In Vivo
- Year
- 2025
- DOI
- 10.21873/invivo.13924
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Taiwan
- Health Condition
- Systemic Lupus Erythematosus
- Body System
- Cardiovascular
TL;DR
Molecular hydrogen therapy may help reduce fatigue and improve heart and immune function in patients with lupus, without the side effects of traditional treatments.
Key Finding
A lupus patient with heart failure who received molecular hydrogen therapy showed improvements in cardiac function, reduced autoimmune markers, and significant fatigue reduction while tapering off steroids.
Summary
This report describes a single patient with lupus (an autoimmune disease affecting multiple organs) and heart failure who received molecular hydrogen therapy alongside standard treatments. Over several months, the patient showed improvements in heart function, reduced levels of disease-related antibodies, changes in immune cells, and less fatigue. She was also able to reduce her steroid dose while staying stable.
Practical Takeaway
This is a single case report, which is the lowest level of evidence and cannot establish whether hydrogen therapy actually caused the improvements or whether they would occur in other lupus patients. While the results are interesting, much larger and more rigorous studies would be needed before drawing any conclusions about hydrogen's role in treating lupus or autoimmune disease.
Abstract (excerpt)
Background/aim: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multi-organ inflammation and damage across multiple organs, typically managed with steroids and immunomodulators. However, prolonged use of these treatments is often associated with significant side…